Benutzerspezifische Werkzeuge

Publikationen 2015

Aust DE, Bläker H (2015). Histological diagnosis and complications of celiac disease. Update according to the new S2k guidelines. Pathologe 36(2): 197-205


Borkowetz A, Platzek I, Toma M, Laniado M, Baretton G, Froehner M, Koch R, Wirth M, Zastrow S (2015). Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. BJU Int [epub ahead of print]


Cojoc M, Mäbert K, Muders MH, Dubrovska A (2015). A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol 31: 16-27


Daubner D, Spieth S, Pablik J, Zöphel K, Paulus T, Laniado M (2015). Hibernoma-two patients with a rare lipoid soft-tissue tumour. BMC Med Imaging 15: 4


Foersch S, Sperka T, Lindner C, Taut A, Rudolph K, Breier G, Boxberger F, Rau TT, Hartmann A, Stürzl M, Wittkopf N, Haep L, Wirtz S, Neurath MF, Waldner MJ (2015). VEGFR2 signaling prevents colorectal cancer cell senescence to promote tumorigenesis in mice with colitis. Gastroenterology 149(1): 177-189


Froehner M, Koch R, Novotny V, Heberling U, Propping S, Litz RJ, Hübler M, Baretton GB, Hakenberg OW, Wirth MP (2015). Lee mortality index as comorbidity measure in patients undergoing radical cystectomy. Springerplus 4: 55


Froehner M, Koch R, Heberling U, Novotny V, Oehlschlaeger S, Hübler M, Baretton GB, Hakenberg OW, Wirth MP (2015).Decreased overall and bladder cancer- specific mortality with adjuvant chemotherapy after radical cystectomy: multivariable competing risk analysis. Eur Urol [epub ahead of print]


Jackson S, Schaefer J, Meinhardt M, Reichmann H (2015). Mitochondrial abnormalities in the myofibrillar myopathies. Eur J Neurol [epub ahead of print]


Kahlert C, Lerbs T, Pecqueux M, Herpel E, Hoffmeister M, Jansen L, Brenner H, Chang-Claude J, Bläker H, Kloor M, Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U, Reissfelder C, Weitz J, Aust D, Koch M (2015). Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer. Int J Cancer 137(9): 2104-13


Kast K, Link T, Friedrich K, Petzold A, Niedostatek A, Schoffer O, Werner C, Klug SJ, Werner A, Gatzweiler A, Richter B, Baretton G, Wimberger P (2015). Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treat 150(3): 621-9


Keck B, Wach S, Taubert H, Zeiler S, Ott OJ, Kunath F, Hartmann A, Bertz S, Weiss C, Hönscheid P, Schellenburg S, Rödel C, Baretton GB, Sauer R, Fietkau R, Wullich B, Krause FS, Datta K, Muders MH (2015). Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients. Int J Cancer 136(2): 443-51

Kirchberg J, Aust D, Fritzmann J, Folprecht G, Weitz J (2015). Genetisch stratifizierte Darmkrebstherapie. Forum 30(2): 127-133


Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K,Münch A; The Working Group of Digestive Diseases of the European Society of Pathology (ESP); The European Microscopic Colitis Group (EMCG) (2015). Histology of Microscopic Colitis - Review with Practical Approach for Pathologists. Histopathology 66(5): 613-26


Meinel J, Radad K, Rausch WD, Reichmann H, Gille G (2015). Cabergoline protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture. Folia Neuropathol 53(1): 29-40


Papathomas TG, Oudijk L, Persu A, Gill AJ, van Nederveen F, Tischler AS, Tissier F, Volante M, Matias-Guiu X, Smid M, Favier J, Rapizzi E, Libe R, Currás-Freixes M, Aydin S, Huynh T, Lichtenauer U, van Berkel A, Canu L, Domingues R, Clifton-Bligh RJ, Bialas M, Vikkula M, Baretton G, Papotti M, Nesi G, Badoual C, Pacak K, Eisenhofer G, Timmers HJ, Beuschlein F, Bertherat J, Mannelli M, Robledo M, Gimenez-Roqueplo AP, Dinjens WN, Korpershoek E, de Krijger RR (2015). SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Mod Pathol 28(6): 807-21


Platzek I, Borkowetz A, Toma M, Brauer T, Meissner C, Dietel K, Wirth M, Laniado M (2015). Multiparametric prostate magnetic resonance imaging at 3 T: failure of magnetic resonance spectroscopy to provide added value. J Comput Assist Tomogr 39(5): 674-80


Probst A, Aust D, Märkl B, Anthuber M, Messmann H (2015). Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy 47(2): 113-21


Rad R, Rad L, Wang W, Strong A, Ponstingl H, Bronner IF, Mayho M, Steiger K, Weber J, Hieber M, Veltkamp C, Eser S, Geumann U, Ollinger R, Zukowska M, Barenboim M, Maresch R, Cadiñanos J, Friedrich M, Varela I, Constantino-Casas F,
Sarver A, Ten Hoeve J, Prosser H, Seidler B, Bauer J, Heikenwälder M, Metzakopian E, Krug A, Ehmer U, Schneider G, Knösel T, Rümmele P, Aust D, Grützmann R, Pilarsky C, Ning Z, Wessels L, Schmid RM, Quail MA, Vassiliou G, Esposito I, Liu P, Saur D, Bradley A (2015). A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer. Nat Genet 47(1): 47-56


Tannapfel A, Aust D, Baretton GB, Bläker H, Esposito I, Langner C, Vieth M, Wardelmann E, Kirchner T, Schirmacher P (2015). Remove polyps and discard. Way or wrong way? Pathologe 36(2): 182-5


Thiele S, Göbel A, Rachner TD, Fuessel S, Froehner M, Muders MH, Baretton GB, Bernhardt R, Jakob F, Glüer CC, Bornhäuser M, Rauner M, Hofbauer LC (2015). WNT5A has anti- prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo. J Bone Miner Res 30(3): 471-80

Toma M, Wehner R, Kloß A, Hübner L, Fodelianaki G, Erdmann K, Füssel S, Zastrow S, Meinhardt M, Seliger B, Brech D, Noessner E, Tonn T, Schäkel K, Bornhäuser M, Bachmann MP, Wirth MP, Baretton G, Schmitz M (2015). Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis. Oncoimmunology 4(6): e1008342


Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson MJ, Fink JL, Holmes O, Kazakoff SH, Leonard C, Newell F, Poudel B, Song S, Taylor D, Waddell N, Wood S, Xu Q, Wu J, Pinese M, Cowley MJ, Lee HC, Jones MD, Nagrial AM, Humphris J, Chantrill LA, Chin V, Steinmann AM, Mawson A, Humphrey ES, Colvin EK, Chou A, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Pettitt JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Niclou SP, Bjerkvig R, Grützmann R, Aust D, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA; Australian Pancreatic Cancer Genome Initiative, Gill AJ, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Pearson JV, Biankin AV, Grimmond SM (2015). Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518(7540): 495-501


Zeugner S, Mayr T, Zietz C, Aust DE, Baretton GB (2015). RNA quality in fresh-frozen gastrointestinal tumor specimens: experiences from the Tumor and Healthy Tissue Bank TU Dresden. Recent Results Cancer Res 199: 85-93


Zienert E, Eke I, Aust D, Cordes N (2015). LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells. Cancer Lett. 364(1): 17-24